Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2 Affecting up to 100,000 people in the U.S. and up to 5.6 ...

Bactrim (sulfamethoxazole/trimethoprim) is a prescription oral tablet used to treat and prevent certain types of bacterial infections. Your dosage will depend on the ...

Please provide your email address to receive an email when new articles are posted on . Nerandomilast is the first oral preferential phosphodiesterase 4B inhibitor approved for progressive pulmonary ...

The regulatory decision is supported by data from the primary analysis of the Phase III BRUIN CLL-313 clinical study.

AbbVie ( ABBV) announced that the U.S. FDA has approved JUVMO (tavapadon) tablets for the treatment of adults with Parkinson's disease, providing a new oral treatment option for a progressive ...

Doxycycline is a generic drug that comes in several forms, including oral tablets, capsules, and delayed-release oral tablets. It’s approved for several conditions in adults and some children. In ...

Formula combines L-leucine, L-valine, L-isoleucine, L-lysine HCl, L-phenylalanine, L-threonine, L-methionine and ...

The broader PROGRESS clinical development program continues to evaluate zilurgisertib in younger children with FOP. Enrollment has been completed in Cohort 2, which includes children aged 6 to under ...

New agreement, effective immediately, adds approximately 21 million Medicare lives (38% of approximately 55 million Medicare lives in the ...